Clinical Evaluation of OBU When Used for Indirect Dental Restorations

Sponsor
Kerr Corporation (Industry)
Overall Status
Recruiting
CT.gov ID
NCT06002880
Collaborator
(none)
160
1
8
29.6
5.4

Study Details

Study Description

Brief Summary

The objective of this study is to evaluate the clinical safety and performance of Optibond Universal (OBU), a single component universal dental adhesive intended for indirect dental restorations according to manufacturer's Instruction For Use.

Condition or Disease Intervention/Treatment Phase
  • Device: Optibond Universal
N/A

Detailed Description

The device used in the study, Optibond Universal (OBU) is a single component universal dental adhesive intended for direct and indirect dental restorations. OBU is formulated to provide reliable bond strength with any etch technique, on all common substrates and in combination with any resin cement without auxiliary products (silane or metal primers) even in absence of light. OBU is intended for general population use by a dental professional.

OBU contains an acidic component to etch the tooth surface in order to allow the adhesive to mechanically adhere to the prepared tooth surface. The adhesive can be used with light or without light cured prior to application of the restorative material. This allows for the adhesive to mechanically and chemically bond to the applied restorative material. OBU is formulated to provide a reliable bond strength, and it's compatible with all etching modes (self-etch, selective etch, and total etch).

Aim/Hypothesis/Objective The primary objective of this study is to evaluate the clinical performance of OBU used in the intended clinical conditions.

The device will undergo evaluation in the following categories:

Functional Properties Endodontic posts Ceramic restorations Composite and metal crowns Pretreatment for indirect restorations Core build-ups

Endpoints:
Primary endpoints:

Evaluation of clinical safety and performance of OBU, a single component universal dental adhesive intended for indirect dental restorations according to manufacturer's Instruction For Use.

(Indirect metal restoration is defined as any restoration made of precious or non-precious alloy such as inlays, onlays, porcelain fused to metal, metal full coverage crown, metal full coverage fixed partial denture). All implant restorations are excluded.

Secondary endpoints:

Post-operative sensitivity, retention, general periodontal health, and general optical properties after baseline, 6 months, 1 year and 2 years post-placement.

The hypothesis to be tested is that OBU is safe and effective in clinical settings when the device is used according to manufacturer's instructions:

H0: P ̂_T-P ̂_C≥ ∆ HA: P ̂_T-P ̂_C< ∆ Where ∆ (delta) refers to the non-inferiority margin set at 10%.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of OBU When Used for Indirect Dental Restorations
Actual Study Start Date :
Jul 14, 2023
Anticipated Primary Completion Date :
Nov 30, 2025
Anticipated Study Completion Date :
Dec 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Post/Core-Total Etch

Endodontic posts and/or cores-Total etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Ceramic-Total Etch

Glass-ceramics-Total etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Metal/Zi-Total Etch

Metal-Zi-Total etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Composite-Total Etch

Composite-Total etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Post/Core-Self Etch

Endodontic posts and/or cores-Self etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Ceramic-Self Etch

Glass-ceramics-Self etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Metal/Zi-Self Etch

Metal-Zi-Self etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Experimental: Composite-Self Etch

Composite-Self etch

Device: Optibond Universal
OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Outcome Measures

Primary Outcome Measures

  1. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [Screening]

    Preoperative sensitivity

  2. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [Preparation, Provisional Restoration (up to 6 weeks from Screening)]

    Preoperative sensitivity

  3. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [48 hours after Cementation (up to 4 weeks from Preparation)]

    Postoperative sensitivity

  4. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [Baseline Followup Assessments (approximately 3 weeks from Cementation)]

    Postoperative sensitivity

  5. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [6-months Followup Assessments (approximately 6 months from Baseline)]

    Postoperative sensitivity

  6. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [1-year Followup Assessments (approximately 1 year from Baseline)]

    Postoperative sensitivity

  7. Sensitivity Questionnaire-Visual Analog Scale 1 to 5 (1=No pain, 5=Worst pain possible) [2-Year Followup Assessments (approximately 2 years from Baseline)]

    Postoperative sensitivity

  8. FDI (World Dental Federation) Clinical Evaluation Criteria-Modified [Baseline Followup Assessments]

    Esthetic Qualities, Functional Properties, Biological Properties (1 clinically excellent-5 clinically poor Scale)

  9. FDI (World Dental Federation) Clinical Evaluation Criteria-Modified [6-months Followup Assessments]

    Esthetic Qualities, Functional Properties, Biological Properties (1 clinically excellent-5 clinically poor Scale)

  10. FDI (World Dental Federation) Clinical Evaluation Criteria-Modified [1-year Followup Assessments]

    Esthetic Qualities, Functional Properties, Biological Properties (1 clinically excellent-5 clinically poor Scale)

  11. FDI (World Dental Federation) Clinical Evaluation Criteria-Modified [2-Year Followup Assessments]

    Esthetic Qualities, Functional Properties, Biological Properties (1 clinically excellent-5 clinically poor Scale)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Is willing to provide voluntary written informed consent in English.

  • Is in good medical health and able to tolerate the dental procedures.

  • Has 1 qualifying either vital or endodontically treated molar and/or premolar that requires an endodontic post and or core build-ups with subsequent indirect restoration or an indirect restoration only. Only 1 tooth per quadrant can be included in the study if more than 1 tooth in need of restoration. The maximum number of restorations will not exceed two per patient.

  • The tooth must be restorable, i.e. without subgingival caries and must have a minimum of 2-3 mm healthy supragingival tooth structure.

  • Study teeth must have an antagonist in the opposite jaw and have a neighboring tooth on at least one side.

  • Study teeth must be vital and without any symptoms suggesting irreversible damage of the pulp, or endodontically treated and hermetically filled according to standards of care (i.e., free of clinical signs and symptoms of periapical pathology).

Exclusion Criteria:
  • Is currently taking part in an evaluation of other dental procedures.

  • Has chronic periodontitis or rampant caries.

  • The study tooth exhibits clinical signs of periapical pathology.

  • The study tooth has a history of self-reported preoperative pulpal problems.

  • The study tooth that has been restored using eugenol containing materials.

  • Study Subjects with severe parafunctional habits or occlusal issues affecting the subject teeth.

  • Women who are pregnant (self-reported). It is standard of care to postpone routine dental procedures and radiographed until after pregnancy.

  • Women who are breast feeding.

  • Known allergy to methacrylates or other components of resin composites, local anesthetics, or metals used for dental restorations.

  • An employee of the sponsor or members of their immediate family.

  • Condition affecting salivary flow (e.g., salivary gland disorder, Sjögren's Syndrome, xerogenic medications).

  • Are unwilling or unable to have dental radiographs or photographs taken of their dentition and soft tissues.

  • Unable to return to the recall visits.

  • Any other condition which is the view of the investigator may affect the ability of a patient to complete the study.

  • Teeth with implant restorations.

  • Third molars.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nova Southeastern University, College of dental Medicine Fort Lauderdale Florida United States 33328

Sponsors and Collaborators

  • Kerr Corporation

Investigators

  • Principal Investigator: Sibel Antonson, NSU CDM

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sibel Antonson, Professor and Assistant Dean for Research and Development, Nova Southeastern University
ClinicalTrials.gov Identifier:
NCT06002880
Other Study ID Numbers:
  • Kerr 04-2022
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023